Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 43

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 43
---
011,546 |     |             $6.54 |     | $(58,709)    |
| 2023 |     |    $2,209,795 |     |      $513,651 |     |     $1,178,729 |     |   $399,137 |     |            $13.42 |     | $(68,960)    |
| 2022 |     |    $3,576,440 |     |    $(519,251) |     |     $2,129,278 |     | $(599,868) |     |            $37.66 |     | $(73,317)    |

| (1) | For each year shown, the PEO wasDavid H. Mack, Ph.D., our President and Chief Executive Officer. Please see the section titled “Executive Compensation—Summary Compensation Table” for additional information. |

| (2) | Amounts in this column represent the “Total” column set forth in the SCT. Please see the footnotes to the SCT for further detail regarding the amounts in these columns. |

| (3) | The dollar amounts reported in these columns represent the amounts of “compensation actually paid.” The amounts are computed in accordance with Item 402(v) of Regulation S-K by deducting and adding the amounts in the following reconciliation tables from the “Total” column of the SCT (pursuant to SEC rules, fair value at each measurement date is computed in a manner consistent with the fair value methodology used to account for share-based payments in our financial statements under GAAP). |

| (4) | Non-PEO NEOs reflect the average SCT total compensation and average CAP for the following executives by fiscal year: |

2024: Deepika Jalota, Pharm.D. and Michael Carulli 2023: Winston Kung and Deepika Jalota, Pharm.D. 2022: Leila Alland, M.D. and Winston Kung

| PEO SCT Total to CAP Reconciliation                                               |     |       2024 |     |       2023 |     |       2022 |
| SCT Total Compensation                                                            |     | $4,760,281 |     | $2,209,795 |     | $3,576,440 |
| SCT Option and Stock Awards(1)                                                    |     | -3,817,215 |     | -1,328,712 |     | -2,814,415 |
| Year End Fair Value